Award-winning health JPA Health recently earned Med Comms Agency of the Year at the 2025 Manny Awards, highlighting strong market credibility and recognition that can be leveraged to win new health and pharma clients seeking proven performers.

Expansion and M&A The company has grown through acquisitions, including AKT Health in London, expanding its geographic footprint and capabilities. This suggests opportunities to cross-sell integrated global PR, medical comms, and investor relations services.

IR Practice Launch Launching an Investor Relations practice in early 2025 indicates a pivot to serve pharmaceutical, biotechnology, and medical device clients with IR needs, presenting a cross-sell path to existing health clients seeking stakeholder communications.

Data-driven health A tech stack spanning Adobe Analytics, Databricks, Salesforce, BigQuery and Azure signals strong capabilities in analytics-driven campaigns, enabling data-backed narrative work for pharma brands and patient-centric programs.

Global scale, mid-market Revenue range ($50M–$100M) with 51–200 employees positions JPA Health as a mid-market health-focused agency capable of scalable campaigns for mid-to-large pharma, biotech, and medical device clients, including international expansion.